ArticleJMIR cancer2026

An Information Tool Incorporating Real-World Outcome Data for Women With Metastatic Breast Cancer Eligible for Treatment With a CDK4/6 Inhibitor: Development and Evaluation.

Ellen G Engelhardt et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.